MSM is pleased to announce the appointment of Dr. Edward Kislauskis to its Scientific Advisory Board

MSM is pleased to announce the appointment of Dr. Edward Kislauskis to its Scientific Advisory Board. Dr. Kislauskis is an expert in preclinical research and a recognized thought leader on the topic of animal models of human diseases. He co-founded Biomedical Research Models, Inc. (Worcester), Hygeia Therapeutics, Inc. (Holden), and Endocellutions, Inc. (Marshfield) where he is VP Research. Dr. Kislauskis is also active consultant to a growing number of life science companies. Dr. Albert Zlotnik, the Chairman of the SAB said, "MSM is at a critical juncture where expertise in pre-clinical development is crucial to the company's evolution. Dr. Kislauskis' expertise will prove invaluable to the Company's evolutions from a discovery phase company to a development company.